American Marconi Wireless News - News from Boston, Massachusetts, the USA and the world, around the clock every day

LONDON, UNITED KINGDOM / ACCESS Newswire / April 28, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces its final audited results for the year ended 31 December 2024. The Annual Report is available to view on the Company's website at https://hemogenyx.com/.

Empire Metals Confirms Extensive High-Grade Titanium Zones at Pitfield

Highlights:The 2025 Winter Program concluded with 6,997 metres (m) drilled across 14 holes.Drill hole CS25-028 encountered eight (8) spodumene pegmatite intervals, with the widest interval of 50.9 m of continuous spodumene pegmatite, along with additional noteworthy intercepts of 21.5 m and 19.3 m.Drill hole CS25-036 encountered 13 spodumene pegmatite intervals, with the widest interval of 64.3 m of continuous spodumene pegmatite, along with additional noteworthy intervals of 22.3 m, 18.1 m and 12.7 m. Hole 36 ended in pegmatite at a depth of 308.6 m due to time constraints.Assays are pending on all 14 drill holes completed in the 2025 Winter Program.The northeast-southwest strike of the main zone has increased to 1,500 m (previously 850 m at the end of 2024).

CALGARY, AB / ACCESS Newswire / April 28, 2025 / Primary Hydrogen Corp. (TSXV:HDRO)(FRA:83W0)(OTCQB:HNATF) ("Primary" or the "Company") is pleased to announce the engagement of Trent Sizemore and his firm, Lonewolf Energy Inc., to support the Company's U.S. project expansion strategy.

OSAKA, JP / ACCESS Newswire / April 28, 2025 / On April 28, Sichuan Week, China Pavilion at Expo 2025 Osaka, Kansai, Japan, officially kicks off, marking a significant milestone as the first Chinese province to host activities at the level of provinces. Running from April 28 to 30, Sichuan Week is centered around the theme "The Splendid Bashu Culture, Together For A Better Future."

GOLETA, CA / ACCESS Newswire / April 28, 2025 / Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, automotive, AI, defense and aerospace, communication, and quantum computing, announced today that it will visit the Nasdaq MarketSite in Times Square and ring the Closing Bell in celebration of the recent listing of its common stock on the Nasdaq Capital Market.

International Star Inc. Re-Engages T Bone Capital and Todd Masse to Drive Strategic Growth and Deal Flow

TORONTO, ON / ACCESS Newswire / April 28, 2025 / Aclara Resources Inc. ("Aclara" or the "Company") (TSX:ARA) is pleased to announce the official inauguration of its semi-industrial heavy rare earths pilot plant facility in Aparecida de Goiania, Goias, Brazil. The ceremony was attended by key government authorities from the State of Goias, the Municipality of Nova Roma, and representatives from federal agencies and international embassies.

Fourth Quarter 2024 Results Demonstrate Building Momentum in Business

CRANBROOK, BC / ACCESS Newswire / April 28, 2025 / Eagle Plains Resources Ltd. (TSX-V:EPL) ("EPL" or "Eagle Plains") is pleased provide an update on its 25% owned Olson gold property (the "OlsonProject") in partnership with SKRR Exploration Inc. (SKRR)(B04Q) ("SKRR"), which owns 75% of the Olson Project.

CALGARY, ALBERTA / ACCESS Newswire / April 28, 2025 / Consumer Choice Award is proud to recognize Ultra-Lite Doors as the 2025 winner in the Garage Door Dealers category for Southern Alberta. This respected distinction highlights the Canadiancompany's long-standing commitment to exceptional product quality, expert installation, and responsive customer service throughout the region.

Company Announces Improved Q4 and Year-End Financial Results

Putting the "Paper When Possible, Plastic When Useful" Principle into Action

BRIDGEWATER, NEW JERSEY / ACCESS Newswire / April 28, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, recently announced positive feedback from the U.S. Food and Drug Administration (FDA) regarding TH104. The agency confirmed that no additional clinical trials appear to be necessary prior to a 505(b)(2) New Drug Application (NDA) submission. TH104 is a buccal film formulation, of nalmefene specifically designed for rapid absorption with a potential for bypassing liver metabolism. This allows TH104 to be suitable for the temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders who may be exposed to high-potency opioids, including weaponized fentanyl and its analogues.

SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announces that today its partner, Clinical Laserthermia Systems AB (publ) (CLS), completed the submission of its 510(k) application to the FDA, expanding the indication of the ClearPoint Prism Neuro Laser Therapy System to include 1.5 T MRI guidance.

Company thanks the outgoing CEO for his many years of oversight that has accelerated growth in Afinida and Trucept companies.

Ambient AI technology that seamlessly integrates into the EHR to improve ED and inpatient documentation and clinical workflows

Clear Start Tax Shares What Not to Do When You’re Behind With the IRS—and the Smartest Ways to Start Resolving Your Debt

AUSTIN, TX / ACCESS Newswire / April 28, 2025 / Living Security, the global leader in human risk defense, today unveils powerful adaptive intelligence capabilities within its Unify platform. By fusing human expertise from its Human Intelligence Team (HInT), advanced AI phishing simulations, and industry-wide threat telemetry, Unify now delivers a minimum of 3X more visibility into human risk compared to outdated security awareness tools. This advancement is validated by third-party research from Cyentia.

LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial aims to accelerate the development of effective treatments for PSP, a rare and fatal neurodegenerative disease. Additional compounds to be evaluated in the trial are expected to be announced later this year.

Latest Agreements Continue Network's Rapid Global Growth in Over 100 Countries Across Five Continents

The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for crofelemer for MVID; Click here to registerThere are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid managementThis data was presented at the Annual ELITE PED-GI Congress by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology and the primary investigator for this study

Initial order in Europe highlights Ondas' continued momentum as an emerging defense technology prime contractor, delivering next-generation autonomous systems to address evolving aerial threats and support critical national security operationsThis latest purchase order builds on a series of international contracts and operational milestones, reinforcing the Company's rapid growth and expanding presence in defense and security markets

tZERO's Special Purpose Broker Dealer (one of two in the US) and Tokenization Unit continue to lead compliant Digital Securities end-to-end lifecycle, new capabilities to enhance transparency, facilitate additional utility features and enable third-party broker-dealer interoperability in the future

PHOENIX, ARIZONA / ACCESS Newswire / April 28, 2025 / Crexendo®, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication as a service (UCaaS) offerings, including voice, video, contact center, and managed IT services tailored to businesses of all sizes, today announced that VOIPLY, a rapidly growing nationwide cloud communications provider for business and residential customers, has selected Crexendo's NetSapiens platform as their next generation growth platform.

CHINO HILLS, CA / ACCESS Newswire / April 28, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces today its collaboration and licensing agreement with an undisclosed emerging drug development partner. This partnership accentuates SOHM's leadership in gene editing and cell engineering.

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work utilizing a variety of clinically relevant radionuclides, significantly expanding the organization's capabilities in the development and assessment of targeted radiotherapeutics.

CHENGDU, CHINA / ACCESS Newswire / April 28, 2025 / Wetouch Technology Inc. (Nasdaq:WETH) ("Wetouch" or the "Company") a leading provider of medium to large sized projected capacitive touchscreens, today announced its unaudited financial results for the year ended December 31, 2024. The company reported revenue of $42.3 million and earnings per share (EPS) of $0.48, reflecting strong performance across its diverse client base.

ROCKY MOUNT, NC / ACCESS Newswire / April 28, 2025 / Ted E. Whitehurst, President and CEO of PB Financial Corporation (OTCQX:PBNC), the holding company for Providence Bank, announced today that the Board of Directors approved a quarterly cash dividend of $0.58 per share on common stock outstanding to shareholders of record at the close of business on May 8, 2025. The dividend is payable on May 23, 2025. This is an increase of approximately 9.43% from the dividend paid during the 2nd quarter of 2024. This represents a $2.32 per share dividend on an annualized basis and a dividend yield of approximately 4.99% (based on closing price on April 25, 2025 of $46.50 per share).

STURGIS, MI / ACCESS Newswire / April 28, 2025 / Sturgis Bancorp, Inc. (OTCQX:STBI) today reported for the first quarter of 2025:

MIAMI, FLORIDA / ACCESS Newswire / April 28, 2025 / SMX Plc. (NASDAQ:SMX) just turbocharged its global expansion with not one but two transformative partnerships in the ASEAN region. In the span of a week, SMX announced inking high-impact agreements with Aegis Packaging and Skypac Packaging - Singapore-based leaders in coating technologies and flexible plastics, respectively. These deals are beyond milestones scored - they mark a powerful swing in commercial momentum that positions SMX as a dominant, even irreplaceable, force in the unyielding drive toward a transparent and accountable circular economy.

TEL AVIV, IL / ACCESS Newswire / April 28, 2025 / Shelfie-Tech Ltd. (the "Company" or "Shelfie"), is pleased to announce that it has received a letter from the Canadian Securities Exchange (the "CSE") confirming conditional approval to list its common shares for trading on the CSE (the "Listing"). The Conditional Approval follows the receipt by Shelfie of a receipt for its (Final) Long Form Prospectus dated April 22, 2025 relating to the securities of Shelfie (the "Prospectus"). A copy of the Prospectus can be found under the Company's profile at www.sedarplus.ca.